AHA GUIDELINES Bundle (free trial)

Lower Extremity Peripheral Artery Disease 2024

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521560

Contents of this Issue

Navigation

Page 50 of 55

51 11.2.2. Adjunctive Therapies to Minimize Tissue Loss in ALI COR LOE Recommendations 1 C-EO 1. Patients with ALI should be monitored and treated for compartment syndrome with fasciotomy after revascularization (endovascular or surgical, including catheter-directed thrombolysis) to prevent the sequelae of reperfusion injury and need for amputation. 2a B-NR 2. In patients with ALI with a threatened but salvageable limb (ie, category IIa or IIb), prophylactic fasciotomy is reasonable based on the clinical findings. 2a C-EO 3. In patients with ALI and prolonged ischemia in whom revascularization (endovascular or surgical, including catheter-directed thrombolysis) is performed, concurrent and early amputation can be beneficial to avoid the morbidity of reperfusion. 11.3. Diagnostic Evaluation for the Cause of ALI COR LOE Recommendations 1 C-EO 1. In patients with ALI, a comprehensive medical history and physical examination should be performed to determine the cause of thrombosis or embolization. 2a C-LD 2. In patients with ALI, testing for a cardiovascular cause of thromboembolism can be useful. 11.2.3. Anticoagulation for ALI COR LOE Recommendation 1 C-EO 1. In patients with ALI, regardless of cause or anatomic level of occlusion, systemic anticoagulation with unfractionated heparin should be administered on diagnosis unless contraindicated.

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Lower Extremity Peripheral Artery Disease 2024